EX-10.17 3 a15-23151_1ex10d17.htm EX-10.17 CONFIDENTIAL TREATMENT REQUESTED November 30, 2015 Via Email Jennifer Low, M.D., Ph.D., M.H.Sc. Re: Terms of Transition and Separation Dear Dr. Low:Terms of Transition and Separation • May 5th, 2020 • California
Contract Type FiledMay 5th, 2020 JurisdictionThis letter confirms the agreement (“Agreement”) between you and Loxo Oncology, Inc. (the “Company”) concerning the terms of your transition and separation from employment and offers you certain benefits to which you would not otherwise be entitled, conditioned upon your provision of a general release of claims and covenant not to sue now and upon the Separation Date (defined below) as provided herein. If you agree to the terms outlined herein, please sign and return this Agreement to me in the timeframe outlined below.
November 30, 2015Terms of Transition and Separation • March 15th, 2016 • Loxo Oncology, Inc. • Pharmaceutical preparations • California
Contract Type FiledMarch 15th, 2016 Company Industry JurisdictionThis letter confirms the agreement (“Agreement”) between you and Loxo Oncology, Inc. (the “Company”) concerning the terms of your transition and separation from employment and offers you certain benefits to which you would not otherwise be entitled, conditioned upon your provision of a general release of claims and covenant not to sue now and upon the Separation Date (defined below) as provided herein. If you agree to the terms outlined herein, please sign and return this Agreement to me in the timeframe outlined below.